Navigation Links
Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
Date:2/24/2011

IRVING, Texas, Feb. 24, 2011 /PRNewswire/ -- Novation, the leading health care supply contracting company, announced today that Medtronic Inc. has cancelled five contracts with Novation that cover cardiovascular and orthopedic products.  Novation is owned by VHA Inc. and the University HealthSystem Consortium (UHC), and VHA and UHC members represent $2 billion in annual purchases for Medtronic in these product categories. Novation has been in constant contact with Medtronic and has made every effort to maintain member value in these high cost categories. Medtronic stated in a letter to Novation that the company wanted to manage their business relationships with hospitals locally, rather than through a national GPO contract.

"This move will likely raise costs for member organizations by eliminating the price protection that members benefit from through Novation's national agreements," said Pete Allen, senior vice president of sourcing operations at Novation. "In addition, through our contracts members generate cooperative returns, and have more favorable terms and conditions. The contracts also protect members from pricing confidentiality clauses, eliminate freight fees, and mandate that new technology is added to contracts when the technologies are released."

In response to Medtronic's action, 16 of the leading U.S. not-for-profit hospitals and academic medical centers sent an open letter to the chairman and chief executive officer of Medtronic Inc., stating their 'extreme disappointment' with Medtronic during this time of unprecedented cost pressures. Hospitals in this country are facing more than $155 billion in reduced government reimbursement over the next ten years; placing an unprecedented burden on their existing fragile financial viability.  Dissolution of the Novation contracts will force health care organizations to develop individual agreements with Medtronic in order to obtain discounted pricing and new terms and conditions. 

"Members have told us that Medtronic's unilateral decision to cancel its agreements with Novation will likely increase their costs and impair the efficiency with which they conduct business," stated Allen.

Novation has heard from many members that some medical device manufacturers are insisting on strict pricing confidentiality clauses in their local contracts as a condition of the agreement.  These so-called "gag" clauses, which are not present in Novation agreements, prohibit hospitals from sharing pricing information with group purchasing organizations and other third parties that provide services designed to manage and control costs, such as benchmarking and auditing services.

It is unclear whether Medtronic will allow hospitals that desire to purchase Medtronic product through a local agreement the ability to share purchasing information with their GPOs or other advisors retained to help manage costs.

Allen continued, "If medical device manufacturers are successful in limiting hospitals' ability to understand and discuss pricing with outside parties, then they will be able to sell at price points that are not rational or relevant. That dynamic will keep prices artificially high and increase costs to the hospitals."

In response to the complexities associated with contracts for high cost medical devices, especially in light of the Medtronic actions, Novation has taken the initiative to significantly enhance the valuable contracting support services health care providers are receiving at no additional expense.  

Effective immediately and continuing through 2011, Novation will provide hands-on member support for the negotiation of all agreements for major cardiac and orthopedic devices, if members request this support.  This service may be provided either indirectly through education and benchmarking assistance, or directly as the designated agent for contract negotiation on the member's behalf.

About Novation

Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites. Novation provides alliance members contract and price management and spend management services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase nearly $40 billion in 2010.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
2. PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
3. Renhuang Cancels Third Quarter 2010 Conference Call
4. Essilor Cancels Four Million Shares
5. Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
6. MAQUET Cardiovascular Launches New VASOVIEW 6 PRO Endoscopic Vessel Harvesting System
7. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
8. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
9. Reportlinker Adds Europe Cardiovascular Devices Market Outlook to 2016
10. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
11. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... NEW YORK , March 29, 2017 ... ... society and the public safety in regulating marijuana, but economic ... revenues, job creation, and reduced law enforcement costs. However, to ... like those provided by SinglePoint, Inc. (OTC: SING) ( SING ...
(Date:3/29/2017)... , March 29, 2017 Neurim Pharmaceuticals ... Exeltis will obtain exclusive marketing rights for Neurim,s new Rx PedPRM ... ... targeted to treat sleep disorders in children with Autism Spectrum Disorders ... sleep medication approved for children. The collaboration with Exeltis ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ... release financial results for the year ended December ... 26, 2017. The results are being released later ... financial statements will include the operations and balances ... 1, 2016.  This release and filing date meets ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Technology™, is the first technology to directly address the resolution to globally reduce ... Technology™ is a patented compound of FDA and TTB approved ingredients that when ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... San Mateo, CA (PRWEB) , ... ... ... Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science ... manuscript leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry ...
Breaking Medicine News(10 mins):